OPK Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
OPKO Health Inc. Stock Analysis OPK
United States Health Care Small Cap OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. The company is headquartered in Miami, Florida and currently employs 2,997 full-time employees. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Read More OPK Chart
OPKO Health Inc vs S&P 500 Comparative Returns
Analysis of OPK stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- OPKO Health Inc... (OPK...) -9.52%
- S&P 500 -4.27%
OPKO Health Inc Underperformed S&P 500 by 5.25%
1Y Performance
- OPKO Health Inc... (OPK...) 0.76%
- S&P 500 8.86%
OPKO Health Inc Underperformed S&P 500 by 8.10%
3Y Performance
- OPKO Health Inc... (OPK...) -56.96%
- S&P 500 37.21%
OPKO Health Inc Underperformed S&P 500 by 94.17%
5Y Performance
- OPKO Health Inc... (OPK...) -50%
- S&P 500 92.3%
OPKO Health Inc Underperformed S&P 500 by 142.30%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$1.33Volume
1.96MP/E Ratio (TTM)
-52 Week Range
Market Cap
1.05BAvg. Volume
3.36MDividend Yield
-Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 2.14 | 2.6 | 1.3 | 1.12 | - |
EBIT per Share (TTM) | 0.09 | -0.02 | -0.32 | -0.2 | - |
Earnings per Share (EPS) (TTM) | - | -0.05 | 0 | 0 | - |
EPS Forward | - | - | -0.46 | -0.25 | -0.08 |
Super Investors
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
